12:00 AM
Sep 16, 2013
 |  BC Week In Review  |  Financial News  |  Other Financial News

DRI Capital financial update

DRI Capital closed its Drug Royalty III fund at $1.5 billion, above the firm's $1 billion target. DRI Capital acquires royalties from pharma and biotechs, research institutes,...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >